RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $441,000 | -83.5% | 390,066 | -56.5% | 0.12% | -82.8% |
Q1 2022 | $2,679,000 | +15.0% | 896,100 | +1.9% | 0.70% | +19.1% |
Q4 2021 | $2,329,000 | -20.7% | 879,000 | +8.7% | 0.59% | -24.8% |
Q3 2021 | $2,937,000 | +177.3% | 809,000 | +231.6% | 0.78% | +252.5% |
Q2 2021 | $1,059,000 | +12.4% | 244,000 | -11.4% | 0.22% | -0.9% |
Q1 2021 | $942,000 | +226.0% | 275,500 | +74.7% | 0.22% | +168.7% |
Q2 2020 | $289,000 | +17.5% | 157,700 | 0.0% | 0.08% | -19.4% |
Q1 2020 | $246,000 | -27.0% | 157,700 | 0.0% | 0.10% | -11.2% |
Q4 2019 | $337,000 | +14.2% | 157,700 | 0.0% | 0.12% | +4.5% |
Q3 2019 | $295,000 | -17.8% | 157,700 | +14.6% | 0.11% | -17.8% |
Q2 2019 | $359,000 | +1.4% | 137,600 | 0.0% | 0.14% | -11.8% |
Q1 2019 | $354,000 | +12.0% | 137,600 | 0.0% | 0.15% | -2.5% |
Q4 2018 | $316,000 | -28.5% | 137,600 | 0.0% | 0.16% | -13.7% |
Q3 2018 | $442,000 | +13.6% | 137,600 | 0.0% | 0.18% | 0.0% |
Q2 2018 | $389,000 | -87.8% | 137,600 | -84.7% | 0.18% | -88.3% |
Q1 2018 | $3,193,000 | -16.3% | 901,933 | -8.3% | 1.55% | -24.4% |
Q4 2017 | $3,816,000 | +238.9% | 983,478 | +121.8% | 2.06% | +194.0% |
Q3 2017 | $1,126,000 | -7.0% | 443,478 | 0.0% | 0.70% | -19.1% |
Q2 2017 | $1,211,000 | -22.7% | 443,478 | -6.3% | 0.86% | -34.8% |
Q1 2017 | $1,567,000 | +25.6% | 473,478 | +39.3% | 1.32% | +52.5% |
Q3 2016 | $1,248,000 | -69.7% | 340,000 | -81.6% | 0.87% | -73.4% |
Q2 2016 | $4,119,000 | +5.5% | 1,847,087 | -1.6% | 3.26% | -3.0% |
Q1 2016 | $3,903,000 | +16.1% | 1,876,492 | +69.1% | 3.37% | +12.3% |
Q4 2015 | $3,363,000 | +22.7% | 1,109,740 | 0.0% | 3.00% | +10.2% |
Q3 2015 | $2,741,000 | -23.0% | 1,109,740 | 0.0% | 2.72% | -9.7% |
Q2 2015 | $3,562,000 | -10.1% | 1,109,740 | 0.0% | 3.01% | -1.0% |
Q1 2015 | $3,962,000 | +133.1% | 1,109,740 | +48.1% | 3.04% | +126.2% |
Q4 2014 | $1,700,000 | – | 749,066 | – | 1.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |